Latest news
How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 12:12:36 GMTOM: Q2 2026 saw stable revenue, improved margins, and a narrowed net loss amid ongoing legal and market challenges - TradingViewTradingView · Thu, 06 Aug 2026 21:17:01 GMTPACB: Gross profit doubled and operating loss narrowed sharply in H1 2026 amid restructuring - TradingViewTradingView · Wed, 05 Aug 2026 21:32:31 GMTHow Investors Are Reacting To Diversified Healthcare Trust (DHC) Narrowing Losses Amid Softer Revenue - simplywall.stsimplywall.st · Tue, 04 Aug 2026 12:29:29 GMTRARE: Q2 2026 revenue rose 28% to $214M, with net loss narrowing to $92M amid restructuring - TradingViewTradingView · Tue, 04 Aug 2026 10:02:15 GMTHow Investors May Respond To Piedmont Realty Trust (PDM) Narrowing Losses Amid Modest Revenue Growth - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 31 Jul 2026 03:18:00 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Earnings Forecast Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 01:42:45 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Healthcare Earnings Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 01:34:36 GMT